06:09 PM EDT, 07/01/2025 (MT Newswires) -- WW International said late Tuesday it expanded its collaboration with Novo Nordisk ( NVO ) to improve access to the weight loss drug Wegovy injection through its clinics.

As part of the expanded partnership, eligible WeightWatchers clinic members can obtain the FDA-approved GLP-1 medication for $299 during July under a limited-time pricing offer from Novo Nordisk ( NVO ).

WeightWatchers said it will streamline the prescription process through NovoCare Pharmacy, with CenterWell Pharmacy serving as the dispensing pharmacy and handling home delivery. The company will also offer bundled pricing, shipment tracking, and other integrated features to improve the member experience.

The companies also plan to explore research initiatives evaluating the benefits of combining Wegovy with WeightWatchers' nutrition and behavioral support program as part of a broader integrated care model.